Rather, the common property in all such cases from series 2, which progressed to CNS metastatic disease was overexpression of Pin1 (data not shown), consistent with the critical role of this protein in promoting aggressive clinical phenotypes in breast cancers expressing mutant p53 (Girardini et al, 2011). The gene discussed is TP53; the disease is metastatic neoplasm.